financetom
Business
financetom
/
Business
/
Marathon Oil narrowly beats first quarter profit estimates on higher prices
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marathon Oil narrowly beats first quarter profit estimates on higher prices
May 1, 2024 3:03 PM

(Reuters) - Oil and gas firm Marathon Oil ( MRO ) narrowly beat first-quarter profit estimates on Wednesday, helped by higher oil and liquefied natural gas (LNG) pricing.

Crude oil prices in the quarter mirrored prices from the previous year as production cuts by OPEC+ countries offset lower demand, helping oil producers such as Marathon Oil ( MRO ).

The Houston-based company said average price for crude oil and condensate in the United States was up about 1% at $75.39 per barrel (bbl) and international price was up 5.6% to $61.86 per bbl.

"We remain fully on track to deliver a 2024 program that provides a sector-leading combination of free cash flow, capital efficiency and shareholder returns," said CEO Lee Tillman.

Quarterly oil production was down 2.7% to 181,000 barrels per day (bpd), compared with a year earlier.

The company said January winter storms negatively affected its quarterly production by 4,000 net bopd, with the impact primarily concentrated in the Bakken.

The company said its average realized price for natural gas sold as LNG was $7.21 per million cubic feet (mmcf) in the reported quarter.

The company reported an adjusted profit of 55 cents per share for the quarter ended March 31, compared with analysts' average estimate of 54 cents per share, according to LSEG data.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Lumen's Completes Debt Restructuring Deal -- Shares Rise in Early Trading
Lumen's Completes Debt Restructuring Deal -- Shares Rise in Early Trading
Mar 22, 2024
10:00 AM EDT, 03/22/2024 (MT Newswires) -- Lumen Technologies ( LUMN ) said Friday it has completed agreements with creditors holding over $15 billion of the company's outstanding debt as part of a restructuring plan. Following the closing of the transaction agreements, Lumen is in a strengthened liquidity position, the company said, with a new roughly $1 billion revolving credit...
Switzerland removes 12 people from Russia sanctions list
Switzerland removes 12 people from Russia sanctions list
Mar 22, 2024
March 22 (Reuters) - Switzerland has removed 12 people from its Russia sanctions list over the war in Ukraine, the State Secretariat for Economic Affairs (SECO) said on Friday. Among them is Arkady Volozh, a co-founder of Russian internet giant Yandex ( YNDX ), who recently cut ties with the Russian business and condemned the invasion of Ukraine. He was...
Brady Insider Sold Shares Worth $477,100, According to a Recent SEC Filing
Brady Insider Sold Shares Worth $477,100, According to a Recent SEC Filing
Mar 22, 2024
10:01 AM EDT, 03/22/2024 (MT Newswires) -- Elizabeth P Bruno, Director, on March 20, 2024, sold 8,322 shares in Brady (BRC) for $477,100. Following the Form 4 filing with the SEC, Bruno has control over a total of 333,593 shares of the company, with 333,593 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/746598/000074659824000016/xslF345X03/wk-form4_1711111874.xml Price: 58.41, Change: -0.18, Percent Change: -0.31 ...
Gilead Sciences Completes $4.3 Billion Cymabay Acquisition
Gilead Sciences Completes $4.3 Billion Cymabay Acquisition
Mar 22, 2024
09:56 AM EDT, 03/22/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Friday it has completed its $4.3 billion acquisition of CymaBay Therapeutics ( CBAY ). The company said CymaBay's lead product candidate for primary biliary cholangitis, seladelpar, 'complements' its existing liver portfolio. Price: 72.95, Change: -0.14, Percent Change: -0.19 ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved